RNASeq profiling of COVID19-infected patients identified an EIF2AK2 inhibitor as a potent SARS-CoV-2 antiviral Published on 2022-11-012022-11-15 Journal: Clinical and Translational Medicine [키워드] Antiviral EIF2AK2 inhibitor Patient SARS-CoV-2 [저자] Sidharth Jain, Samantha Rego, Steven Park, Yiran Liu, Simone Parn, Kush Savsani, David S Perlin, Sivanesan Dakshanamurthy [Category] SARS, 치료제, PMC URL [DOI] 10.1002/ctm2.1098 All Keywords 【제목키워드】 SARS-CoV-2, Antiviral, Patient, inhibitor, EIF2AK2,